The Food and Drug Administration approved Keytruda monotherapy and in combination with chemotherapy for the front-line treatments of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma.
Use of two medicated mouthwashes reduced pain from oral mucositis during the first four hours after administration; however, the results were not deemed clinically different when compared with placebo.
In this Special Edition of CURE Talks Cancer, we chat with Poison drummer and throat cancer survivor Rikki Rockett about his cancer journey and why it's important to "Open Up and Say... Ahh!" during Oral, Head and Neck Cancer Awareness Week.